Page last updated: 2024-12-05

fenchol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Fenchol is a bicyclic monoterpene alcohol with a characteristic camphor-like odor. It is found in various essential oils, notably from fennel (Foeniculum vulgare), where it contributes to the characteristic flavor. Fenchol exists in two enantiomeric forms: (+)-fenchol and (-)-fenchol, with the (+)-enantiomer being more prevalent in nature. Fenchol exhibits various biological activities, including antibacterial, antifungal, and antioxidant properties. Its synthesis has been investigated through various routes, including the use of terpene precursors and enzymatic reactions. The study of fenchol is driven by its potential applications in the pharmaceutical, food, and fragrance industries. Fenchol's unique structure and biological activities make it a promising candidate for developing new therapeutic agents and natural products. '

fenchol: RN given refers to cpd with unspecified isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15406
CHEMBL ID1907996
SCHEMBL ID58038
MeSH IDM0088933

Synonyms (47)

Synonym
410q2gk1hf ,
unii-410q2gk1hf
fenchyl alcohol
1,3,3-trimethyl-2-norbornanol
1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol
fenchol
bicyclo(2.2.1)heptan-2-ol, 1,3,3-trimethyl-
fema no. 2480
3,3-dimethyl-8,9-dinorbornan-2-ol
ai3-00733
einecs 216-639-5
1,3,3-trimethylbicyclo(2.2.1)heptan-2-ol
AB-131/40897226
2-norbornanol, 1,3,3-trimethyl-
bicyclo[2.2.1]heptan-2-ol, 1,3,3-trimethyl-
SMP2_000026
1632-73-1
2,2,4-trimethylbicyclo[2.2.1]heptan-3-ol
dtxcid9021970
NCGC00257282-01
dtxsid1041970 ,
tox21_303498
cas-1632-73-1
AKOS006230299
CHEMBL1907996
FT-0626396
FT-0604567
FT-0604559
S5379
(+)-fenchol
SCHEMBL58038
bicyclo[2.2.1]heptan-2-ol, 1,3,3-trimethyl-, (1r-endo)-
1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol #
F0921
1,3,3-trimethyl-2-norborneol
fema 2480
Q417941
BS-16080
(1s,2r,4r)-1,3,3-trimethyl-bicyclo[2.2.1]heptan-2-ol
mfcd00066640
fenchyl alcohol (od)
CCG-266251
D70275
HY-N7107
CS-0081213
SY115529
EN300-296384

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID624614Specific activity of expressed human recombinant UGT2A12000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID624608Specific activity of expressed human recombinant UGT1A42000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (17.65)18.7374
1990's1 (5.88)18.2507
2000's4 (23.53)29.6817
2010's5 (29.41)24.3611
2020's4 (23.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.75 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index79.51 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (51.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (23.53%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (76.47%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]